Home » Topics » Disease categories and therapies » Immune

Immune
RSS

North American Vaccine to seek NeisVac-C approval in U.K. shortly

Jan. 20, 2000

QS-21 license granted to Elan

Jan. 20, 2000

Avant's cholera vaccine to enter phase IIb trial

Jan. 19, 2000

Isolation of unnamed tick-borne bacterium causing HGE patented by Aquila

Jan. 17, 2000

FDA accepts NDA for new Rapamune formulation

Jan. 14, 2000

KF-20444 has potent immunosuppressive activity

Jan. 14, 2000

Licensing opportunity from NIH: live attenuated RSV and PIV for use as human vaccines

Jan. 10, 2000

Medarex antibody therapy reduces inflammation in vivo

Jan. 6, 2000

Agents for immune or inflammatory disorders from Boehringer Ingelheim

Jan. 4, 2000

Chiron prepares highly immunogenic and bactericidal N. meningitidis vaccine

Jan. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...